Alnylam Pharmaceuticals | ALNY - Market Capitalization

Stock Price
286.98
Daily Change
-6.47 -2.20%
Monthly
-10.36%
Yearly
0.59%
Q2 Forecast
281.21

Alnylam Pharmaceuticals reported $37.39B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 9.7B 920M May/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Takeda JPY 8.33T 681.01B May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026
Xencor USD 795M 98M May/2026